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Pregnancy in patients with Eisenmenger’s syndrome is associated with a high mortality. This article reports two cases of women 
with Eisenmenger’s syndrome (secondary to two different primary cardiac defects) who presented with near-term pregnancies. 
Both the patients underwent successful elective Caesarean section with slowly titrated epidural anaesthesia. Nebulised 
prostaglandin E1(PGE1) analogue, alprostadil, administered immediately post-delivery resulted in a significant drop in systolic 
pulmonary artery pressures as measured from tricuspid regurgitant jet by transthoracic echocardiography. The postoperative 
period was uneventful in both patients. A slow induction of epidural anaesthesia can be a safe mode of anaesthesia for Caesarean 
section in pregnant patients with Eisenmenger’s syndrome. Nebulised alprostadil intraoperatively or postoperatively in the 
intensive care unit (ICU) is readily available and a relatively cheap option as a selective pulmonary vasodilator in developing 
countries.
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Introduction
The management of the obstetric patient with Eisenmenger’s 
syndrome remains a challenge,1 with the mortality rate as high as 
30–70%.2 We report two cases of women with Eisenmenger’s 
syndrome who underwent Caesarean section using similar 
anaesthetic techniques in a tertiary care centre.
Case history
Both patients were admitted with a history of long-standing 
shortness of breath. Neither woman was receiving any definitive 
treatment nor had any prior antenatal visit to our hospital. 
Patient consent was obtained prior to the procedure.
Patient 1
The first patient was a 32-year-old G1P0+0 of bodyweight 50 kg 
and height 155 cm (BMI = 20.8), with New York Heart Association 
(NYHA) class III classification, who presented at 35  weeks 
gestation with a diagnosis of patent ductus arteriosus (PDA). 
Positive findings on her physical examination were a parasternal 
heave, pansystolic murmur of tricuspid regurgitation (TR), short 
ejection systolic murmur in the pulmonary area, loud P2 with 
narrow split S2, bilateral vesicular breath sounds with mild right-
sided basal crepitations and a baseline pulse oximeter oxygen 
saturation (SpO2) of 90–94% on room air. She had a haematocrit 
of 42%. Her echocardiography report showed large (10 mm) PDA 
at the ampulla with severe pulmonary artery hypertension (PAH) 
with a pulmonary artery systolic pressure (PASP) of 100 mm Hg, 
bidirectional shunt and Eisenmengerisation, moderate TR, and 
right ventricular hypertrophy. She was optimised for two weeks 
with oral frusemide 40 mg once daily (OD), oral digoxin 0.25 mg 
OD, and oral sildenafil 25 mg twice a day (BID).
Patient 2
The second patient was a 25-year-old G1P0+0 of body weight 
45  kg and height 150  cm (BMI = 20), with a NYHA class III 
classification, who presented at 36  weeks gestation. She had 
been recently diagnosed with a ventricular septal defect (VSD). 
Positive findings on her physical examination were a pansystolic 
murmur of TR, loud single S2 and a baseline SpO2 of 90–91% on 
room air. She had a haematocrit of 31.5%. Her echocardiography 
report revealed a 6 mm perimembranous VSD with severe PAH, 
PASP = 103 mm Hg, bidirectional shunt and Eisenmengerisation, 
moderate TR, and mild aortic regurgitation. She was optimised 
for two weeks with oral sildenafil 25 mg BID.
Both patients underwent elective Caesarean section with a 
slowly titrated epidural to provide surgical anaesthesia. In the 
operation theatre, an intravenous infusion of Ringer’s lactate was 
started and intravenous antibiotics were administered. An 
arterial line was inserted to allow continuous blood pressure (BP) 
monitoring, and central venous access was obtained. The shunt 
across the defect, together with PA systolic pressures, was 
monitored intraoperatively at regular intervals from TR jet 
analysis using transthoracic echocardiography (TTE) with 
Doppler measurements. The right radial artery was cannulated 
and the right internal jugular vein was catheterised. Supplemental 
oxygen was provided via facemask started at 6 litres per minute.
Baseline vital parameters were:
Patient 1: Blood pressure  =  118/68  mm Hg, heart rate (HR) = 
102 bpm, sinus rhythm, SpO2 = 92%.
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Patient 2: BP  =  138/82  mm Hg, HR  =  112  bpm, sinus rhythm, 
SpO2 = 92% .
An epidural catheter was inserted in a sitting position at the level 
of the L2–L3 intervertebral space in patient 1 and at L3–4 in 
patient 2 using a standard loss-of-resistance technique and 
tested with 3  ml preservative-free 2% lignocaine with 
epinephrine. Titrated incremental doses of local anaesthetic 
were used to achieve a targeted level of sensory block at a height 
of T6 in both patients. Patient 1 received bupivacaine 0.5% 5 ml 
(25 mg) with fentanyl 50 μg initially and a repeat dose of 3 ml 
0.5% (15 mg) bupivacaine after 15 min. Patient 2 was administered 
an initial dose of bupivacaine 5  ml 0.5% (25  mg) along with 
fentanyl 50  μg, and a repeat dose of 4  ml 0.5% (20  mg) 
bupivacaine after 15 min. Both patients achieved a Bromage 
score of 4 and remained haemodynamically stable with central 
venous infusions of milrinone (0.2–0.3  μg/kg/min) and 
phenylephrine (0.2–0.7  μg/kg/min). Healthy newborns with an 
Apgar score of 8 and 9 at 1 and 5 min respectively were delivered 
in both cases.
Immediately post-delivery, 5U oxytocin was infused very slowly 
with uterine massage resulting in a well-contracted uterus. 
Nebulisation with alprostadil 600  μg in 3  ml normal saline 
administered over 20 min resulted in a significant drop in PASP as 
measured from TR jet using TTE (100 to 57 mm Hg in patient 1 
and 103 to 65  mm Hg in patient 2). Intraoperative TTE and 
Doppler monitoring also showed no increase in right to left 
shunt across the respective defect in both patients.
The SpO2 remained close to baseline throughout the surgery. 
TTE monitoring was continued postoperatively in the ICU. Both 
the patients remained haemodynamically stable postpartum. 
They were managed in the semi-recumbent position with 
oxygen therapy. Analgesia was provided with an epidural 
infusion of bupivacaine 0.0625% titrated to effect level of pain, 
and the first dose of prophylactic enoxaparin was administered 
in the evening. The epidural catheter was removed on 
postoperative day (POD) 1.
Phenylephrine and milrinone were slowly titrated down and 
stopped on POD 2 and 3. Both patients were transferred to the 
ward on POD 4 on oral paracetamol 500  mg 6 hourly, oral 
frusemide 40 mg daily, oral sildenafil 25 mg twice daily orally and 
subcutaneous enoxaparin 40  mg daily. Cardiology workup of 
both the neonates was normal. The patients were discharged 
from hospital subsequently on oral aspirin 75 mg daily, frusemide 
40 mg daily, and sildenafil 25 mg twice daily. The women were 
advised to avoid strenuous activity and further pregnancy, and 
to receive regular cardiology follow-up.
Discussion
Eisenmenger’s syndrome is defined as pulmonary hypertension 
with reversed or bidirectional shunt, associated with septal 
defects or patent ductus arteriosus. The provision of anaesthesia 
carries a high risk in these patients.3 The goal of anaesthetic 
management is to maintain systemic vascular resistance (SVR) in 
order to prevent an increase in right to left shunt. Either regional 
or general anaesthesia may be used,3,4 each with its own risks 
and benefits. During general anaesthesia, intermittent positive 
pressure ventilation causes a decrease in venous return and 
cardiac output and an increase in pulmonary artery pressure, 
which together produce an increase in right to left shunt.3 
However, general anaesthesia has been successfully used and is 
preferred in patients receiving antithrombotic drugs due to the 
increased risk of subdural haematoma following epidural 
anaesthesia.5 Single-shot spinal epidural anaesthesia or 
combined-spinal epidural anaesthesia6 leads to a sudden fall in 
SVR and increases right to left shunt.
Continuous spinal anaesthesia has been used successfully in a 
similar case.7 Epidural anaesthesia has been safely used in these 
patients for elective Caesarean section. 8 We chose the technique 
of titrated epidural anaesthesia with incremental doses as the 
slow onset of the block allows compensation for the 
sympathectomy below the level of the block and results in 
relatively stable haemodynamics.
Intravenous (IV) milrinone infusion was titrated to manage the 
pulmonary hypertension9 based on PA pressure measurements 
by transthoracic Doppler echocardiography. But as milrinone 
lacks pulmonary selectivity,9 simultaneous phenylephrine 
infusion was used to combat its systemic vasodilatory effects, 
thereby preventing any sudden fall of blood pressure in the 
presence of the sympatholysis of neuraxial blockade. Following 
delivery, autotransfusion and aorto-caval decompression 
increases blood flow to the right side of the heart and may lead 
to pulmonary hypertensive crisis, right heart failure10 and cardiac 
arrest. We attempted to reduce PA pressures further during this 
vulnerable period immediately after baby delivery by 
administering nebulised PGE1 analogue alprostadil.
Alprostadil (PGE1) is a selective pulmonary vasodilator that has 
been used to reduce shunting in ARDS and to improve pulmonary 
hypertension.11 PGE1 has been used successfully during 
Caesarean section in Eisenmenger’s syndrome.12 Previous case 
reports and non-randomised studies suggest that inhalation of 
aerosolised PGE1 may improve life expectancy in intractable 
pulmonary hypertension.13,14 Intravenous epoprostenol has 
been used successfully in a pregnant patient with Eisenmenger’s 
syndrome.10,15 The long-term neonatal effect is not well known 
with a reported case of neonatal death on the 11th day of life, 
although maternal pulmonary hypertension in pregnancy was 
well managed with IV epoprostenol.10
Aerosolised alprostadil is preferred to the intravenous route as 
the latter may lead to systemic side effects like systemic arterial 
hypotension, and postpartum maternal bleeding. Inhaled nitric 
oxide, although recommended, was not used because of non-
availability in our centre. Inhaled nitric oxide use is not without 
side effects.16 Pulmonary vasodilators including prostaglandins 
are not recommended during pregnancy because of possible 
teratogenicity and adverse effects on uterine circulation.6
The cost and availability of recommended selective pulmonary 
vasodilators (IV epoprostenol, IV/inhaled iloprost, IV/SC 
treprostinil, inhaled nitric oxide)12 is a serious concern in our 
country. Alprostadil may be a cheaper alternative.
The efficacy and reliability of PA pressure measurement from TR 
jet by TTE with Doppler in the perioperative and ICU settings in 
adults has not been as extensively studied and validated as has 
been in done in neonates.17 TR jet measurements do not always 
reflect pulmonary artery pressure and can significantly under- or 
over-estimate it in individual patients.18
We elected not to use a pulmonary artery catheter because of its 
inherent risks,19 the restricted availability and the difficulty of 
inserting it in the correct position. Incorrect placement has the 
potential of tip advancement through the cardiac defect. Our 
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perioperative management was largely guided by monitoring of 
PASP from TR jet utilising noninvasive transthoracic Doppler 
echocardiography instead of an invasive PA catheter.
In conclusion, slow-titrated epidural anaesthesia can be a safe 
mode of anaesthesia for Caesarean section in pregnancy with 
Eisenmenger’s syndrome. Alprostadil, intraoperatively or 
postoperatively in the ICU, is a readily available and cheaper 
option than other pulmonary vasodilators in developing 
countries. Perioperative PA pressure measurement from TR jet 
using TTE for guiding therapy can be a noninvasive and safer 
alternative to pulmonary artery catheterisation.
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